Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 14 | 2026 | 610 | 1.160 |
Why?
|
| Ovarian Neoplasms | 8 | 2026 | 829 | 0.880 |
Why?
|
| Breast Neoplasms | 18 | 2023 | 3303 | 0.830 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2023 | 11 | 0.800 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2026 | 2588 | 0.760 |
Why?
|
| Genetic Counseling | 6 | 2026 | 111 | 0.690 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2021 | 9 | 0.680 |
Why?
|
| Genes, BRCA2 | 13 | 2023 | 162 | 0.660 |
Why?
|
| RNA Helicases | 1 | 2021 | 45 | 0.660 |
Why?
|
| Disease | 1 | 2020 | 92 | 0.610 |
Why?
|
| Genes, BRCA1 | 11 | 2012 | 191 | 0.570 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 470 | 0.530 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 236 | 0.530 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1275 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 2577 | 0.370 |
Why?
|
| Community Participation | 1 | 2012 | 40 | 0.360 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1863 | 0.360 |
Why?
|
| Awareness | 1 | 2012 | 93 | 0.350 |
Why?
|
| Mutation | 11 | 2021 | 4443 | 0.320 |
Why?
|
| Germ-Line Mutation | 5 | 2026 | 404 | 0.290 |
Why?
|
| BRCA1 Protein | 3 | 2023 | 222 | 0.230 |
Why?
|
| Risk Assessment | 5 | 2021 | 2604 | 0.210 |
Why?
|
| Genetic Carrier Screening | 2 | 2008 | 58 | 0.200 |
Why?
|
| BRCA2 Protein | 2 | 2014 | 178 | 0.190 |
Why?
|
| Female | 25 | 2026 | 51997 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2023 | 154 | 0.180 |
Why?
|
| Humans | 30 | 2026 | 98799 | 0.170 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 118 | 0.170 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2021 | 12 | 0.160 |
Why?
|
| Counselors | 1 | 2021 | 7 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 158 | 0.160 |
Why?
|
| Health Equity | 1 | 2023 | 117 | 0.160 |
Why?
|
| Mammography | 2 | 2006 | 505 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 685 | 0.150 |
Why?
|
| Complementary Therapies | 1 | 2020 | 58 | 0.140 |
Why?
|
| Breast Neoplasms, Male | 2 | 2014 | 34 | 0.140 |
Why?
|
| Middle Aged | 15 | 2026 | 29642 | 0.130 |
Why?
|
| Risk Factors | 5 | 2021 | 6295 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 318 | 0.120 |
Why?
|
| Phenotype | 1 | 2023 | 2673 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 563 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 782 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 1305 | 0.110 |
Why?
|
| Aged | 10 | 2026 | 21986 | 0.110 |
Why?
|
| Ovariectomy | 3 | 2009 | 98 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2026 | 11104 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 1120 | 0.090 |
Why?
|
| Adult | 15 | 2026 | 29698 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2009 | 89 | 0.080 |
Why?
|
| Risk Reduction Behavior | 2 | 2026 | 102 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 757 | 0.070 |
Why?
|
| Adult Children | 1 | 2009 | 13 | 0.070 |
Why?
|
| Heterozygote | 2 | 2008 | 393 | 0.070 |
Why?
|
| Systems Integration | 1 | 2008 | 36 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2009 | 75 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2008 | 44 | 0.070 |
Why?
|
| Infertility | 1 | 2008 | 36 | 0.070 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 49 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 129 | 0.070 |
Why?
|
| Health Behavior | 3 | 2020 | 203 | 0.060 |
Why?
|
| Bilirubin | 1 | 2007 | 135 | 0.060 |
Why?
|
| Disclosure | 1 | 2007 | 98 | 0.060 |
Why?
|
| Preimplantation Diagnosis | 1 | 2006 | 6 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2026 | 7461 | 0.060 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2006 | 18 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2006 | 83 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2007 | 178 | 0.060 |
Why?
|
| Mastectomy | 1 | 2008 | 277 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2006 | 232 | 0.060 |
Why?
|
| Prevalence | 2 | 2023 | 1396 | 0.050 |
Why?
|
| Computational Biology | 1 | 2008 | 620 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 832 | 0.050 |
Why?
|
| Male | 7 | 2021 | 47475 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1621 | 0.040 |
Why?
|
| Europe | 1 | 2023 | 360 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2014 | 3242 | 0.040 |
Why?
|
| Age Factors | 1 | 2026 | 1976 | 0.040 |
Why?
|
| Ohio | 1 | 2021 | 43 | 0.040 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2021 | 30 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 42 | 0.040 |
Why?
|
| ROC Curve | 1 | 2002 | 797 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2006 | 861 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1571 | 0.030 |
Why?
|
| Pedigree | 3 | 2008 | 988 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2002 | 1152 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 4837 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 472 | 0.030 |
Why?
|
| Data Collection | 2 | 2008 | 376 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 384 | 0.030 |
Why?
|
| Family Health | 2 | 2009 | 157 | 0.030 |
Why?
|
| Adolescent | 4 | 2009 | 10168 | 0.030 |
Why?
|
| Algorithms | 1 | 2002 | 2005 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2014 | 18 | 0.030 |
Why?
|
| Neoplasms | 2 | 2008 | 3382 | 0.030 |
Why?
|
| Probability | 2 | 2005 | 356 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 267 | 0.020 |
Why?
|
| Chicago | 2 | 2009 | 1520 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 7598 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 19 | 0.020 |
Why?
|
| Fertility Agents, Female | 1 | 2008 | 3 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2008 | 12 | 0.020 |
Why?
|
| Menotropins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Clomiphene | 1 | 2008 | 17 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 77 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 190 | 0.020 |
Why?
|
| Dinucleotide Repeats | 1 | 2007 | 14 | 0.020 |
Why?
|
| Minority Groups | 1 | 2009 | 166 | 0.020 |
Why?
|
| Estrogens | 1 | 2008 | 202 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 195 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2008 | 390 | 0.010 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 43 | 0.010 |
Why?
|
| Public Policy | 1 | 2006 | 64 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 1007 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 484 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 229 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2006 | 282 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 444 | 0.010 |
Why?
|
| Haplotypes | 1 | 2007 | 657 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 716 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 1102 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 675 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 2017 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 1895 | 0.010 |
Why?
|
| United States | 2 | 2006 | 8387 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1276 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 592 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 602 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 295 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 4139 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 554 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 3058 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1946 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1792 | 0.010 |
Why?
|
| Child | 1 | 2007 | 7771 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 1274 | 0.010 |
Why?
|